Advertisement

Acetazolamide-enhanced MR angiography of intracranial aneurysms

  • K. Tsuchiya
  • Y. Mizutani
  • T. Seki
  • J. Hachiya
  • Y. Furuya
Conference paper

Abstract

The purpose of our study was to evaluate the enhancing effect of acetazolamide in three-dimensional time-of-flight magnetic resonance angiography (MRA) for the diagnosis of intracranial aneurysms. MRA obtained at 1.5 T before and after acetazolamide administration was compared in a group of five patients without aneurysms and another group of seven patients with seven aneurysms. In each patient, distal arterial branches were more clearly demonstrated on MRA with the administration of acetazolamide than without. Four of the seven aneurysms (mean diameter, 9.0 mm) were better depicted after the acetazolamide infusion. In the remaining three aneurysms (mean diameter, 4.7 mm), no significant change was noted. This method improves the visualisation of distal small arteries and provides better images of relatively large aneurysms.

Key words

Magnetic resonance angiography Intracranial aneurysm Acetazolamide Contrast media 

References

  1. 1.
    Araki Y, Tanaka H, Ohtani M, Yamamoto H, Yamamoto T, Tsugaguchi I (1992) MR angiography enhanced by sodium acetazolamide (in Japanese). Nippon Act Radiol 52: 1605–1607.Google Scholar
  2. 2.
    Mandai K, Sueyoshi K, Fukunaga R, Nukada M, Ohtani F, Araki Y, Tsukaguchi I, Abe H (1994) Acetazolamide challenge for three-dimensional time-of-flight MR angiography of the brain. AJNR 15: 659–665.PubMedGoogle Scholar
  3. 3.
    Sevick RJ, Tsuruda JS, Schmalbrock P (1990) Three-dimensional time-of-flight MR angiography in the evaluation of cerebral aneurysms. J Comput Assist Tomogr 14: 874–881.PubMedCrossRefGoogle Scholar
  4. 4.
    Ross JS, Masaryk TJ, Modic MT, Ruggieri PM, Haacke EM, Selman WR (1990) Intracranial aneurysms: evaluation by MR angiography. AJNR 11: 449–456.PubMedGoogle Scholar
  5. 5.
    Hauge A, Nicolaysen G, Thorensen M (1983) Acute effects of acetazolamide on cerebral blood flow. Acta Physiol Scand 117: 233–239.PubMedCrossRefGoogle Scholar
  6. 6.
    Vorstrup S, Henriksen L, Paulson OB (1984) Effect of acetazolamide on cerebral blood flow and cerebral metabolic rate for oxygen. J Clin Invest 74: 1634–1639.PubMedCrossRefGoogle Scholar
  7. 7.
    Sullivan HG, Kingsbury TB IV, Morgan ME, Jeffcoat RD, Allison JD, Goode JJ, McDonnell DE (1987) The rCBF response to Diamox in normal subjects and cerebrovascular disease patients. J Neurosurg 67: 525–534.PubMedCrossRefGoogle Scholar
  8. 8.
    Rogg J, Rutigliano M, Yonas H, Johnson DW, Pentheny S, Latchaw RE (1989) The acetazolamide challenge: imaging techniques designed to evaluate cerebral blood flow reserve. AJNR 10: 803–810.Google Scholar
  9. 9.
    Ringelstein EB, Van Eyck S, Mertens I (1992) Evaluation of cerebral vasomotor reactivity by various vasodilating stimuli: comparison of CO2 to acetazolamide. J Cereb Blood Flow Metab 12: 162–168.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1995

Authors and Affiliations

  • K. Tsuchiya
    • 1
  • Y. Mizutani
    • 1
  • T. Seki
    • 1
  • J. Hachiya
    • 1
  • Y. Furuya
    • 1
  1. 1.Department of RadiologyKyorin University School of MedicineMitaka, TokyoJapan

Personalised recommendations